Medicenna Therapeutics Corp. (TSX: MDNA)
1.950
+0.050 (2.63%)
Jul 22, 2024, 9:40 AM EDT
Medicenna Therapeutics Employees
Medicenna Therapeutics had 16 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
16
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-1.59M CAD
Market Cap
145.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bausch + Lomb Corporation | 13,300 |
Curaleaf Holdings, Inc. | 5,650 |
Bausch Health Companies Inc. | 20,270 |
Tilray Brands, Inc. | 1,600 |
WELL Health Technologies Corp. | 1,507 |
Sienna Senior Living Inc. | 12,000 |
Canopy Growth Corporation | 1,029 |
Extendicare Inc. | 23,000 |
Medicenna Therapeutics News
- 25 days ago - Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 26 days ago - Medicenna Announces EMA Approval of its Clinical Trial Application to Expand its Phase 1/2 ABILITY-1 Study to Europe - GlobeNewsWire
- 7 weeks ago - Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeting - GlobeNewsWire
- 7 weeks ago - Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response with MDNA11 in the Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum - GlobeNewsWire
- 2 months ago - Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual Oncology Innovation Forum - GlobeNewsWire
- 2 months ago - Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting - GlobeNewsWire
- 2 months ago - New Buy, Medicenna: Superkine Platform In Oncology - Seeking Alpha
- 2 months ago - Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management - GlobeNewsWire